About T-lymphocyte activation antigen CD86
T-lymphocyte activation antigen CD86 (CD86) is a protein
from Homo sapiens identified by UniProt accession
P42081, 329 residues long.
MolForge cross-references it against 0 known binders and
745 disease associations.
Target properties
| Protein name | T-lymphocyte activation antigen CD86 |
| UniProt accession | P42081 |
| Gene | CD86 |
| Organism | Homo sapiens |
| Length | 329 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (2)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (745)
Diseases linked to this target (Open Targets).
- rheumatoid arthritis · score 0.61
- psoriatic arthritis · score 0.53
- juvenile idiopathic arthritis · score 0.53
- acute graft vs. host disease · score 0.50
- immune system disease · score 0.46
- COVID-19 · score 0.45
- dermatomyositis · score 0.45
- multiple sclerosis · score 0.43
- eosinophil count · score 0.41
- cancer · score 0.39
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P42081-F1 | alphafold | PREDICTED | 80.06 | — |
Amino-acid sequence (329 residues)
MDPQCTMGLS NILFVMAFLL SGAAPLKIQA YFNETADLPC QFANSQNQSL SELVVFWQDQ ENLVLNEVYL GKEKFDSVHS KYMGRTSFDS DSWTLRLHNL QIKDKGLYQC IIHHKKPTGM IRIHQMNSEL SVLANFSQPE IVPISNITEN VYINLTCSSI HGYPEPKKMS VLLRTKNSTI EYDGVMQKSQ DNVTELYDVS ISLSVSFPDV TSNMTIFCIL ETDKTRLLSS PFSIELEDPQ PPPDHIPWIT AVLPTVIICV MVFCLILWKW KKKKRPRNSY KCGTNTMERE ESEQTKKREK IHIPERSDEA QRVFKSSKTS SCDKSDTCF
Explore T-lymphocyte activation antigen CD86 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets